Preview

Obstetrics, Gynecology and Reproduction

Advanced search

Assessment of risk factors and prediction of premature ovarian failure

https://doi.org/10.17749/2313-7347/ob.gyn.rep.2021.273

Full Text:

Abstract

The problem of premature ovarian failure (POF) is currently in the spotlight of obstetricians and gynecologists worldwide. Early diagnosis of this pathology is necessary to prevent the development of serious pathological conditions. The systematization of modern ideas about laboratory and instrumental methods for POF diagnosing, assessing diagnostic value of parameters such as follicle stimulating hormone, anti-Mullerian hormone as well as the count of antral ovarian follicles, intraovarian blood flow and ovarian volume using ultrasound techniques, which can then be used as prognostic criteria for POF comprise a very important modality. Based on the findings obtained, early detection may lead to proposing new prognostic strategies.

About the Authors

L. V. Tkachenko
Volgograd State Medical University, Health Ministry of Russian Federation
Russian Federation

Liudmila V. Tkachenko – MD, Dr Sci Med, Professor, Head of the Department of Obstetrics and Gynecology, Institute of Continuing Medical and Pharmaceutical Education; Research Group «Reproductive Medicine and Reproductive Genetics» 

1 Pavshikh Bortsov Square, Volgograd 400131



I. A. Gritsenko
Volgograd State Medical University, Health Ministry of Russian Federation
Russian Federation

Irina A. Gritsenko – MD, PhD, Associate Professor, Department of Obstetrics and Gynecology, Institute of Continuing Medical and Pharmaceutical Education; Research Group «Reproductive Medicine and Reproductive Genetics» 

1 Pavshikh Bortsov Square, Volgograd 400131



K. Yu. Tikhaeva
Volgograd State Medical University, Health Ministry of Russian Federation
Russian Federation

Ksenia Yu. Tikhaeva – MD, PhD, Associate Professor, Department of Pathophysiology, Clinical Pathophysiology; Research Group «Reproductive Medicine and Reproductive Genetics» 

1 Pavshikh Bortsov Square, Volgograd 400131



N. I. Sviridova
Volgograd State Medical University, Health Ministry of Russian Federation
Russian Federation

Natalia I. Sviridova – MD, Dr Sci Med, Professor, Department of Obstetrics and Gynecology, Institute of Continuing Medical and Pharmaceutical Education; Research Group «Reproductive Medicine and Reproductive Genetics» 

1 Pavshikh Bortsov Square, Volgograd 400131



I. S. Gavrilova
Volgograd State Medical University, Health Ministry of Russian Federation
Russian Federation

Irina S. Gavrilova – MD, PhD (Philosophy), Associate Professor, Department of Medical and Social Technologies with a Course in Pedagogy and Educational Technologies of Additional Professional Education; Research Group «Reproductive Medicine and Reproductive Genetics» 

1 Pavshikh Bortsov Square, Volgograd 400131



V. A. Dolgova
Volgograd State Medical University, Health Ministry of Russian Federation
Russian Federation

Valeriia A. Dolgova – 4 th year Student, Faculty of General Medicine; Research Group «Reproductive Medicine and Reproductive Genetics» 

1 Pavshikh Bortsov Square, Volgograd 400131



E. A. Savostova
Volgograd State Medical University, Health Ministry of Russian Federation
Russian Federation

Ekaterina A. Savostova – 5 th year Student, Faculty of General Medicine; Research Group «Reproductive Medicine and Reproductive Genetics» 

1 Pavshikh Bortsov Square, Volgograd 400131



References

1. European Society for Human Reproduction and Embryology (ESHRE) Guideline Group on POI; Webber L., Davies M., Anderson R. et al. ESHRE Guideline: management of women with premature ovarian insufficiency. Hum Reprod. 2016;5(31):926–37. https://doi.org/10.1093/humrep/dew027.

2. Cordts E.B., Christofolini D.M., Dos Santos A.A. et al. Genetic aspects of premature ovarian failure: a literature review. Arch Gynecol Obstet. 2011;283(3):635–43. https://doi.org/10.1007/s00404-010-1815-4.

3. Golezar S., Ramezani Tehrani F., Khazaei S. et al. The global prevalence of primary ovarian insufficiency and early menopause: a meta-analysis. Climacteric. 2019;22(4):403–11. https://doi.org/10.1080/13697137.2019.1574738.

4. Panay N., Anderson R.A., Nappi R.E. et al. Premature ovarian insufficiency: an International Menopause Society White Paper. Climacteric. 2020;23(5):426–46. https://doi.org/10.1080/13697137.2020.1804547.

5. Nguyen H.H., Milat F., Vincent A. Premature ovarian insufficiency in general practice: meeting the needs of women. Aust Fam Physician.2017;46(6):360–6.

6. Salimova M.D., Nadelyaeva Y.G., Danusevich I.N. Modern concepts of clinical and diagnostic criteria for premature ovarian failure (literature review). [Sovremennye predstavleniya o klinikodiagnosticheskih kriteriyah prezhdevremennoj nedostatochnosti yaichnikov (obzor literatury)]. Acta Biomedical Scientifica. 2020;5(6):42–50. (In Russ.). https://doi.org/10.29413/ABS.2020-5.6.5.

7. Granger E., Tal R. Anti-Müllerian hormone and its predictive utility in assisted reproductive technologies outcomes. Clin Obstet Gynecol. 2019;62(2):238–56. https://doi.org/10.1097/GRF.0000000000000436.

8. Marchenko L.A., Mashaeva R.I. Clinical and laboratory criteria for occult form of premature ovarian failure. [Kliniko-laboratornye kriterii okkul'tnoj formy prezhdevremennoj nedostatochnosti yaichnikov]. Ginekologiya. 2018;20(6):73–6. (In Russ.). https://doi.org/10.26442/20795696.2018.6.180069.

9. Jiao X., Meng T., Zhai Y. et al. Ovarian reserve markers in premature ovarian insufficiency: within different clinical stages and different etiologies. Front Endocrinol (Lausanne). 2021;12:601752. https://doi.org/10.3389/fendo.2021.601752.

10. Guzov I.I., Pecherina E.Yu., Ruzhanskaya A.V. et al. Determination of reference intervals for anti-Müllerian hormone, specific for Russian population. [Opredelenie referentnyh intervalov antimyullerova gormona, specifichnyh dlya rossijskoj populyacii]. Laboratornaya sluzhba. 2019;8(2):25–35. (In Russ.). https://doi.org/10.17116/labs2019802125.

11. Martins W.P., Jokubkiene L. Assessment of the functional ovarian reserve. In: Managing Ultrasonography in Human Reproduction. Eds. S. Guerriero, J.L. Alcazar, W.P. Martins. Springer International Publishing, 2016. 3–12. https://doi.org/10.1007/978-3-319-41037-1_1.

12. Coelho Neto M.A., Ludwin A., Borrell A. et al. Counting ovarian antral follicles by ultrasound: a practical guide. Ultrasound Obstet Gynecol. 2018;51(1):10–20. https://doi.org/10.1002/uog.18945.

13. Depmann M., Broer S.L., van der Schouw Y.T. et al. Can we predict age at natural menopause using ovarian reserve tests or mother’s age at menopause? A systematic literature review. Menopause. 2016;23(2):224–32. https://doi.org/10.1097/GME.0000000000000509.

14. Ignateva R.E., Gustovarova T.A., Dmitrieva E.V. Method for estimation of the ovarian reserve of ovarian status. [Sposob ocenki sostoyaniya ovarial'nogo rezerva yaichnikov]. Patent RF № 2646572 C1, 05.03.2018. Bul. № 7. 9 p. (In Russ.). Available at: https://patents.s3.yandex.net/RU2646572C1_20180305.pdf.

15. Agarwal A., Agarwal S., Verma A., Shukla R.C. Total basal ovarian volume as a marker of ovarian reserve: myth or reality. J Clin Diagn Res. 2018;12(2):TC13–TC16. https://doi.org/10.7860/JCDR/2018/31482.11211.

16. Moreau J., Gatimel N., Cohade C. et al. Mother's age at menopause but not own age at menarche has an impact on ovarian reserve. Gynecol Endocrinol. 2018;34(8):664–5. https://doi.org/10.1080/09513590.2018.1428300 .

17. Mishra G.D., Chung H.F., Cano A. et al. EMAS position statement: predictors of premature and early natural menopause. Maturitas. 2019;123:82–8. https://doi.org/10.1016/j.maturitas.2019.03.008.

18. Volchenok D.A., Tikhonovskaya O.A., Petrov I.A. et al. The state of ovarian reserve in patients with functional ovarian cysts. [Sostoyanie ovarial'nogo rezerva u pacientok s funkcional'nymi kistami yaichnikov]. Journal of Siberian Medical Sciences. 2019;(1):18–27. (In Russ.). https://doi.org/10.31549/2542-1174-2019-1-18-27.

19. Ahmad A.K., Kao C.N., Quinn M. et al. Differential rate in decline in ovarian reserve markers in women with polycystic ovary syndrome compared with control subjects: results of a longitudinal study. Fertil Steril. 2018;109(3):526–31. https://doi.org/10.1016/j.fertnstert.2017.11.012.

20. Pan M.L., Chen L.R., Tsao H.M., Chen K.H. Polycystic ovarian syndrome and the risk of subsequent primary ovarian insufficiency: a nationwide population-based study. Menopause. 2017;24(7):803–9. https://doi.org/10.1097/GME.0000000000000832.

21. Ferreira G.R.V., Tomioka R.B., Aikawa N.E. et al. Ovarian reserve in young juvenile idiopathic arthritis patients. Modern Rheumatology. 2019;29(3):447–51. https://doi.org/10.1080/14397595.2018.1465646.

22. Grossmann B., Saur S., Rall K. et al. Prevalence of autoimmune disease in women with premature ovarian failure. Eur J Contracept Reprod Health Care. 2020;25(1):72–5. https://doi.org/10.1080/13625187.2019.1702638.

23. Szlendak-Sauer K., Jakubik D., Kunicki M. et al. Autoimmune polyglandular syndrome type 3 (APS-3) among patients with premature ovarian insufficiency (POI). Eur J Obstet Gynecol Reprod Biol. 2016;203:61–5. https://doi.org/10.1016/j.ejogrb.2016.05.023.


Supplementary files

Review

For citation:


Tkachenko L.V., Gritsenko I.A., Tikhaeva K.Yu., Sviridova N.I., Gavrilova I.S., Dolgova V.A., Savostova E.A. Assessment of risk factors and prediction of premature ovarian failure. Obstetrics, Gynecology and Reproduction. 0;. (In Russ.) https://doi.org/10.17749/2313-7347/ob.gyn.rep.2021.273

Views: 30


ISSN 2313-7347 (Print)
ISSN 2500-3194 (Online)